Inari Medical, Inc.
NARI
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 153.39M | 145.82M | 143.19M | 132.09M | 126.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 153.39M | 145.82M | 143.19M | 132.09M | 126.37M |
| Cost of Revenue | 19.85M | 19.99M | 18.89M | 17.01M | 14.48M |
| Gross Profit | 133.54M | 125.83M | 124.30M | 115.09M | 111.89M |
| SG&A Expenses | 108.27M | 114.15M | 103.06M | 91.09M | 85.60M |
| Depreciation & Amortization | 2.50M | 2.45M | 2.46M | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.05M | 161.50M | 151.29M | 130.99M | 121.57M |
| Operating Income | -6.66M | -15.68M | -8.10M | 1.10M | 4.79M |
| Income Before Tax | -12.67M | -21.42M | -16.09M | -3.17M | 5.59M |
| Income Tax Expenses | 5.70M | 9.93M | 8.12M | 1.49M | 2.43M |
| Earnings from Continuing Operations | -18.37M | -31.35M | -24.20M | -4.67M | 3.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.37M | -31.35M | -24.20M | -4.67M | 3.16M |
| EBIT | -6.66M | -15.68M | -8.10M | 1.10M | 4.79M |
| EBITDA | -5.03M | -14.20M | -6.73M | 2.51M | 6.23M |
| EPS Basic | -0.31 | -0.54 | -0.42 | -0.08 | 0.06 |
| Normalized Basic EPS | -0.06 | -0.16 | -0.08 | 0.04 | 0.10 |
| EPS Diluted | -0.31 | -0.54 | -0.42 | -0.08 | 0.05 |
| Normalized Diluted EPS | -0.06 | -0.16 | -0.08 | 0.04 | 0.09 |
| Average Basic Shares Outstanding | 58.37M | 58.14M | 57.94M | 57.64M | 57.38M |
| Average Diluted Shares Outstanding | 58.37M | 58.14M | 57.94M | 57.64M | 58.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
